diclofenac has been researched along with docetaxel anhydrous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Hao, JQ; Li, Q; Shen, YX; Sun, GY; Xu, SP | 1 |
| Abad, M; Al-Abdulla, R; Briz, O; Bujanda, L; Herraez, E; Lozano, E; Macias, RIR; Marin, JJG; Perez-Silva, L; Segues, N | 1 |
| Armirotti, A; Catelani, T; Decuzzi, P; Di Mascolo, D; Ferreira, M; Galli, R; Gallotti, AL; Grant, GA; Macchi, F; Marotta, R; Palange, AL; Piccardi, F; Primavera, R; Spanò, R; Wilson, C | 1 |
1 review(s) available for diclofenac and docetaxel anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for diclofenac and docetaxel anhydrous
| Article | Year |
|---|---|
Effect of lumiracoxib on proliferation and apoptosis of human nonsmall cell lung cancer cells in vitro.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2 Inhibitors; Diclofenac; Docetaxel; Humans; Lung Neoplasms; Taxoids | 2008 |
Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP-Binding Cassette Transporters; Cell Line, Tumor; Diclofenac; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Male; Mice, Nude; Middle Aged; Multidrug Resistance-Associated Proteins; Sorafenib; Stomach Neoplasms; Xenograft Model Antitumor Assays | 2020 |
Conformable hierarchically engineered polymeric micromeshes enabling combinatorial therapies in brain tumours.
Topics: Absorbable Implants; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line; Diclofenac; Docetaxel; Drug Implants; Female; Humans; Mice; Mice, Nude; Polylactic Acid-Polyglycolic Acid Copolymer; Xenograft Model Antitumor Assays | 2021 |